REGIONAL BACILLUS CALMETTE-GUÉRIN LYMPHADENITIS AFTER INITIATING ANTIRETROVIRAL THERAPY IN AN INFANT WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTION

We report the case of a male infant with vertically acquired HIV infection who developed suppurative regional BCG lymphadenitis 9 months after immunization, after combination antiretroviral therapy was commenced.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Pediatric infectious disease journal 1998-07, Vol.17 (7), p.660-662
Hauptverfasser: Sharp, Mary J, Mallon, Dominic F. J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 662
container_issue 7
container_start_page 660
container_title The Pediatric infectious disease journal
container_volume 17
creator Sharp, Mary J
Mallon, Dominic F. J
description We report the case of a male infant with vertically acquired HIV infection who developed suppurative regional BCG lymphadenitis 9 months after immunization, after combination antiretroviral therapy was commenced.
doi_str_mv 10.1097/00006454-199807000-00021
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80041072</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80041072</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4651-83d2ffed7db8fb64c6d2fb7d1b613338e74847738bf0783284b2bff2dc3f4843</originalsourceid><addsrcrecordid>eNqFkk-O0zAUxi0EGkrhCEheIHYBO3ZtZxkybmMpSauMC-rKyh9HU0inM3GrEUfgBnOfuRgOLd0hLNnW8_d79tP7DADE6BNGEf-M_GB0RgMcRQJxHwV-hvgFmOAZCQMUCf4STJCIcEAYE6_BG-e-e4RQjK7AVcQE4xRPwFMpF2pZxBn8Eicqy9Y3MImzXGotg8X6-VepCpht8lUaX8tCaXUD47mWJVRjEGtVLGBcaFVKXS6_qtLfo1NZxquNJ7zi17nX4TelU5iu8_Ekz9fF8lrOVaJkkWygT_Ov6s1KQjzyMtG-orfgVVf1zr4771Og51InaZAtF8qXGDSUzXAgSBt2nW15W4uuZrRhPq55i2uGCSHCcioo50TUHeKChILWYd11YduQzitkCj6err0f9g9H6w5mt3WN7fvqzu6PzgiEfMd4-F8Qezui0Dd4CsQJbIa9c4PtzP2w3VXDT4ORGc0zf80zF_PMH_N86vvzG8d6Z9tL4tktr38465Vrqr4bqrtm6y5YSChlYsToCXvc9wc7uB_98dEO5tZW_eHW_OvrkN_oD6Wj</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16459200</pqid></control><display><type>article</type><title>REGIONAL BACILLUS CALMETTE-GUÉRIN LYMPHADENITIS AFTER INITIATING ANTIRETROVIRAL THERAPY IN AN INFANT WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTION</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Sharp, Mary J ; Mallon, Dominic F. J</creator><creatorcontrib>Sharp, Mary J ; Mallon, Dominic F. J</creatorcontrib><description>We report the case of a male infant with vertically acquired HIV infection who developed suppurative regional BCG lymphadenitis 9 months after immunization, after combination antiretroviral therapy was commenced.</description><identifier>ISSN: 0891-3668</identifier><identifier>EISSN: 1532-0987</identifier><identifier>DOI: 10.1097/00006454-199807000-00021</identifier><identifier>PMID: 9686741</identifier><identifier>CODEN: PIDJEV</identifier><language>eng</language><publisher>Baltimore, MD: Williams &amp; Wilkins</publisher><subject>AIDS/HIV ; Anti-HIV Agents - therapeutic use ; BCG Vaccine - adverse effects ; Biological and medical sciences ; Epidemiology. Vaccinations ; General aspects ; HIV Infections - congenital ; HIV Infections - drug therapy ; HIV-1 ; Humans ; Immunocompromised Host ; Infant ; Infectious diseases ; Lymphadenitis - etiology ; Lymphadenitis - microbiology ; Male ; Medical sciences ; Mycobacterium bovis - isolation &amp; purification ; Tropical medicine</subject><ispartof>The Pediatric infectious disease journal, 1998-07, Vol.17 (7), p.660-662</ispartof><rights>Williams &amp; Wilkins 1998. All Rights Reserved.</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4651-83d2ffed7db8fb64c6d2fb7d1b613338e74847738bf0783284b2bff2dc3f4843</citedby><cites>FETCH-LOGICAL-c4651-83d2ffed7db8fb64c6d2fb7d1b613338e74847738bf0783284b2bff2dc3f4843</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2344681$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9686741$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sharp, Mary J</creatorcontrib><creatorcontrib>Mallon, Dominic F. J</creatorcontrib><title>REGIONAL BACILLUS CALMETTE-GUÉRIN LYMPHADENITIS AFTER INITIATING ANTIRETROVIRAL THERAPY IN AN INFANT WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTION</title><title>The Pediatric infectious disease journal</title><addtitle>Pediatr Infect Dis J</addtitle><description>We report the case of a male infant with vertically acquired HIV infection who developed suppurative regional BCG lymphadenitis 9 months after immunization, after combination antiretroviral therapy was commenced.</description><subject>AIDS/HIV</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>BCG Vaccine - adverse effects</subject><subject>Biological and medical sciences</subject><subject>Epidemiology. Vaccinations</subject><subject>General aspects</subject><subject>HIV Infections - congenital</subject><subject>HIV Infections - drug therapy</subject><subject>HIV-1</subject><subject>Humans</subject><subject>Immunocompromised Host</subject><subject>Infant</subject><subject>Infectious diseases</subject><subject>Lymphadenitis - etiology</subject><subject>Lymphadenitis - microbiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mycobacterium bovis - isolation &amp; purification</subject><subject>Tropical medicine</subject><issn>0891-3668</issn><issn>1532-0987</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkk-O0zAUxi0EGkrhCEheIHYBO3ZtZxkybmMpSauMC-rKyh9HU0inM3GrEUfgBnOfuRgOLd0hLNnW8_d79tP7DADE6BNGEf-M_GB0RgMcRQJxHwV-hvgFmOAZCQMUCf4STJCIcEAYE6_BG-e-e4RQjK7AVcQE4xRPwFMpF2pZxBn8Eicqy9Y3MImzXGotg8X6-VepCpht8lUaX8tCaXUD47mWJVRjEGtVLGBcaFVKXS6_qtLfo1NZxquNJ7zi17nX4TelU5iu8_Ekz9fF8lrOVaJkkWygT_Ov6s1KQjzyMtG-orfgVVf1zr4771Og51InaZAtF8qXGDSUzXAgSBt2nW15W4uuZrRhPq55i2uGCSHCcioo50TUHeKChILWYd11YduQzitkCj6err0f9g9H6w5mt3WN7fvqzu6PzgiEfMd4-F8Qezui0Dd4CsQJbIa9c4PtzP2w3VXDT4ORGc0zf80zF_PMH_N86vvzG8d6Z9tL4tktr38465Vrqr4bqrtm6y5YSChlYsToCXvc9wc7uB_98dEO5tZW_eHW_OvrkN_oD6Wj</recordid><startdate>199807</startdate><enddate>199807</enddate><creator>Sharp, Mary J</creator><creator>Mallon, Dominic F. J</creator><general>Williams &amp; Wilkins</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>199807</creationdate><title>REGIONAL BACILLUS CALMETTE-GUÉRIN LYMPHADENITIS AFTER INITIATING ANTIRETROVIRAL THERAPY IN AN INFANT WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTION</title><author>Sharp, Mary J ; Mallon, Dominic F. J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4651-83d2ffed7db8fb64c6d2fb7d1b613338e74847738bf0783284b2bff2dc3f4843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>AIDS/HIV</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>BCG Vaccine - adverse effects</topic><topic>Biological and medical sciences</topic><topic>Epidemiology. Vaccinations</topic><topic>General aspects</topic><topic>HIV Infections - congenital</topic><topic>HIV Infections - drug therapy</topic><topic>HIV-1</topic><topic>Humans</topic><topic>Immunocompromised Host</topic><topic>Infant</topic><topic>Infectious diseases</topic><topic>Lymphadenitis - etiology</topic><topic>Lymphadenitis - microbiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mycobacterium bovis - isolation &amp; purification</topic><topic>Tropical medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sharp, Mary J</creatorcontrib><creatorcontrib>Mallon, Dominic F. J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Pediatric infectious disease journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sharp, Mary J</au><au>Mallon, Dominic F. J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>REGIONAL BACILLUS CALMETTE-GUÉRIN LYMPHADENITIS AFTER INITIATING ANTIRETROVIRAL THERAPY IN AN INFANT WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTION</atitle><jtitle>The Pediatric infectious disease journal</jtitle><addtitle>Pediatr Infect Dis J</addtitle><date>1998-07</date><risdate>1998</risdate><volume>17</volume><issue>7</issue><spage>660</spage><epage>662</epage><pages>660-662</pages><issn>0891-3668</issn><eissn>1532-0987</eissn><coden>PIDJEV</coden><abstract>We report the case of a male infant with vertically acquired HIV infection who developed suppurative regional BCG lymphadenitis 9 months after immunization, after combination antiretroviral therapy was commenced.</abstract><cop>Baltimore, MD</cop><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>Williams &amp; Wilkins</pub><pmid>9686741</pmid><doi>10.1097/00006454-199807000-00021</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0891-3668
ispartof The Pediatric infectious disease journal, 1998-07, Vol.17 (7), p.660-662
issn 0891-3668
1532-0987
language eng
recordid cdi_proquest_miscellaneous_80041072
source MEDLINE; Journals@Ovid Complete
subjects AIDS/HIV
Anti-HIV Agents - therapeutic use
BCG Vaccine - adverse effects
Biological and medical sciences
Epidemiology. Vaccinations
General aspects
HIV Infections - congenital
HIV Infections - drug therapy
HIV-1
Humans
Immunocompromised Host
Infant
Infectious diseases
Lymphadenitis - etiology
Lymphadenitis - microbiology
Male
Medical sciences
Mycobacterium bovis - isolation & purification
Tropical medicine
title REGIONAL BACILLUS CALMETTE-GUÉRIN LYMPHADENITIS AFTER INITIATING ANTIRETROVIRAL THERAPY IN AN INFANT WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTION
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T20%3A52%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=REGIONAL%20BACILLUS%20CALMETTE-GU%C3%89RIN%20LYMPHADENITIS%20AFTER%20INITIATING%20ANTIRETROVIRAL%20THERAPY%20IN%20AN%20INFANT%20WITH%20HUMAN%20IMMUNODEFICIENCY%20VIRUS%20TYPE%201%20INFECTION&rft.jtitle=The%20Pediatric%20infectious%20disease%20journal&rft.au=Sharp,%20Mary%20J&rft.date=1998-07&rft.volume=17&rft.issue=7&rft.spage=660&rft.epage=662&rft.pages=660-662&rft.issn=0891-3668&rft.eissn=1532-0987&rft.coden=PIDJEV&rft_id=info:doi/10.1097/00006454-199807000-00021&rft_dat=%3Cproquest_cross%3E80041072%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16459200&rft_id=info:pmid/9686741&rfr_iscdi=true